SCHEMBL4748698

SCHEMBL4748698

CCN1C(=O)NC(C)C1=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.48
ADORA3 P0DMS8 1/20 0.48
MAPT P10636 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
KMT2A Q03164 2/20 0.44
F2 P00734 1/20 0.42
ELANE P08246 1/20 0.42
CTSG P08311 1/20 0.42
CTRC Q99895 1/20 0.42
ALDH1A1 P00352 3/20 0.37
GMNN O75496 1/20 0.37
THPO P40225 1/20 0.37
BLM P54132 1/20 0.37
PMP22 Q01453 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
MGLL Q99685 1/20 0.37
POLB P06746 1/20 0.32
GAA P10253 1/20 0.32
MEN1 O00255 1/20 0.32
ATAD2 Q6PL18 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9260455 0.79 MAPT (0.43) LMNAADORA3MAPTL3MBTL1KMT2A
SCHEMBL8726371 0.79 KMT2A (0.54) MAPTL3MBTL1KMT2AMGLLPOLB
SCHEMBL21387269 0.76 MAPT (0.41) LMNAADORA3MAPTL3MBTL1KMT2A
SCHEMBL5147348 0.76 KMT2A (0.47) LMNAADORA3MAPTL3MBTL1KMT2A
SCHEMBL1362913 0.74 LMNA (0.47) LMNAADORA3MAPTKMT2AF2
SCHEMBL22063690 0.74 LMNA (0.47) LMNAADORA3MAPTKMT2AF2
SCHEMBL8726551 0.74 MAPT (0.71) LMNAMAPTL3MBTL1KMT2AALDH1A1
SCHEMBL9826491 0.74 KMT2A (0.40) MAPTL3MBTL1KMT2A
SCHEMBL1362950 0.73 LMNA (0.46) LMNAADORA3MAPTL3MBTL1KMT2A
SCHEMBL28840093 0.72 LMNA (0.45) LMNAADORA3MAPTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113906018-B Bradykinin B2 receptor antagonists 法瓦里斯有限责任公司 2024-04-12 CN disclosed
EP-3983402-A1 1-((S)-1-(3-CHLORO-5-FLUORO-2-((4-(1H-PYRAZOL-1-YL)-2-METHYLQUINOLIN-8-YLOXY)METHYL)PHENYL)ETHYL)-IMIDAZOLIDINE-2,4-DIONE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ (BK) B2 RECEPTOR ANTAGONIST FOR TREATING SKIN DISEASES Pharvaris GmbH (CH) 2022-04-20 EP disclosed
EP-3383860-B1 APELIN RECEPTOR AGONISTS AND METHODS OF USE BRISTOL MYERS SQUIBB CO (US) 2021-01-20 EP disclosed
EP-3331872-B1 NOVEL SUBSTITUTED GLYCINE DERIVED FXIA INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2019-09-25 EP disclosed
EP-2958897-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 Senomyx, Inc. (US) 2015-12-30 EP disclosed
WO-2014130582-A2 COMPOUNDS USEFUL AS MODULATORS OF TRPM8 SENOMYX, INC. (US) 2014-08-28 WO disclosed
CN-1129942-B Aza spiro-compounds acting on the cholinergic system with muscarinic agonist activity ISRAEL INST BIOLOG RES 2011-08-10 CN disclosed
WO-2008136842-A1 POLY( CARBONATE-CO-UREA) COPOLYMERS SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2008-11-13 WO disclosed
CN-1129942-A Aza spiro-compounds acting on the cholinergic system with muscarinic agonist activity ISRAEL INST BIOLOG RES (IL) 1996-08-28 CN disclosed